LoyaltyLobby
After Marriott’s board was surprised about the sudden passing of Arne Sorenson, who was diagnosed with pancreatic cancer two years ago and held both positions, they today chose the new Chief Executive Officer (CEO) and President.
The new CEO is Mr. Anthony Capuano, who has been with Marriott since 1995, and President is Stephanie Linnartz, another Marriott longtimer since 1997.
You can access Marriott here.
Marriott International Appoints Anthony Capuano as New CEO And Stephanie Linnartz as President
Marriott Internationalâs (NASDAQ: MAR) Board of Directors announced today that Anthony âTonyâ Capuano has been appointed Chief Executive Officer and has joined the companyâs Board of Directors, effective immediately. He was previously Group President, Global Development, Design and Operations Services. The Board of Directors also announced that Stephanie Linnartz, previously Group President, Consumer Operations, Technology and Emerging
Marriott Appoints Tony Capuano as CEO and Stephanie Linnartz as President
(23 Feb 2021) Marriott has appointed Anthony “Tony” Capuano as Chief Executive Officer and Stephanie Linnartz as President, effective immediately.
Tony was previously Group President, Global Development, Design and Operations Services, whilst Stephanie Linnartz worked as Group President, Consumer Operations, Technology and Emerging Businesses.
“Tony has played a critical role in Marriott’s growth over the last decade,” said J.W. “Bill” Marriott, Jr., Executive Chairman and Chairman of the Board, Marriott International. “He will be a terrific leader as we continue to advance our growth strategy while also navigating the market
Marriott International Appoints Anthony Capuano as New CEO And Stephanie Linnartz as President hospitalitynet.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hospitalitynet.org Daily Mail and Mail on Sunday newspapers.
Published: Feb 19, 2021 By Alex Keown
PICI – Bristol Myers Squibb veteran Ute Dugan was named Senior Vice President of Clinical Research at the Parker Institute for Cancer Immunotherapy (PICI). She will oversee PICI’s clinical development, regulatory affairs and translational medicine efforts, with a focus on overcoming immunotherapy resistance and advancing novel breakthrough treatment combinations. At BMS, she was head of Worldwide Oncology External Medical Affairs, where she created research collaboration models to advance immune-oncology treatments together with partners in academia, professional societies and non-profit organizations. Dugan originally joined BMS as executive director of Global Clinical Research during the formation of the development teams for the pioneering I-O medicines ipilimumab and nivolumab. Before that, her career included stints at Roche/Genentech and Aventis.
Effective 01 March 2021GE T&D India announced the appointment of Mahesh Palashikar on the Board as Chairman. Mahesh assumes the role of Chairman effective 1 March 2021 and succeeds Vishal K Wanchoo who resigned
from Board upon assuming new responsibility with another company, post retirement from GE.
The company also co-opted Emanuel Bartolini, GE Grid Solutions global Chief Commercial Officer on the Board
of the Company as Director w.e.f. 1 March 2021 or the date of allotment of Director Identification Number
whichever is later. Nagesh Tilwani who is the Whole-time Director has resigned from the Board in view of
increased responsibilities within the GE group.